New prostate cancer test
Researchers at the Universities of Surrey and East Anglia have developed a urine test to diagnose prostate cancer and predict whether patients will require treatment up to five years earlier than standard clinical methods.
The experimental new test called ‘PUR’ (Prostate Urine Risk), also identifies men who are up to eight times less likely to need treatment within five years of diagnosis.
Prostate cancer is the most common cancer among men in the UK. It is hoped that the breakthrough could help many avoid an unnecessary initial biopsy and repeated invasive follow-ups for ‘low risk’ patients on active surveillance.
This test will revolutionise how we diagnose and treat prostate cancer. ‘‘
Hardev Pandha, Professor of Medical Oncology at the University of Surrey, said: “The difficulty in determining if tumours are aggressive or have the potential to become so often leads to unnecessary procedures causing needless worry to patients and their families and puts further strain on NHS resources. This test will revolutionise how we diagnose and treat prostate cancer.”